检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin,Nitin Jain,Marcela V Maus,Nicolas Boissel,Charlotte Graham,Agnieszka Jozwik,Deborah Yallop,Marina Konopleva,Matthew J Frigault,Takanori Teshima,Koji Kato, Floriane Boucaud,Svetlana Balandraud,Athos Gianella-Borradori,Florence Binlich,Ibtissam Marchiq,Sandra Dupouy,Maria Almena-Carrasco, Matthieu Pannaux,Sylvain Fouliard

The Lancet Haematology（2022）

引用 26|浏览18
暂无评分
摘要
Servier.
更多
查看译文
关键词
lymphoblastic leukaemia,first-in-class,t-cell,b-cell,dose-escalation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要